Kidneys, heart and diabetes: Science and practice

The Royal Society of Medicine invite you to join their multidisciplinary event to learn about approaches to reduce cardiovascular complications associated with diabetes, and the challenges associated with this.

The benefits and potential side effects of novel anti-diabetes agents will be discussed, and you will be updated on the latest results from clinical trials focusing on SGLT2 inhibitors and GLP-1 receptor agonists.

The event will promote collaboration between different specialisms, including cardiologists, endocrinologists and general practitioners. 

Find out more and register on the Royal Society of Medicine website today.

Register